This clinical-stage biopharmaceutical company recently had one of its treatments rejected for FDA approval. Now the company is cutting its workforce.
A calendar of virtual and IRL gatherings, including resources for founders, networking opportunities and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results